Viewing Study NCT05444894

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-31 @ 2:34 PM
Study NCT ID: NCT05444894
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-02
First Post: 2022-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)
Sponsor: Editas Medicine, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Transfusion Dependent Beta Thalassemia View
None Hemoglobinopathies View
None Thalassemia Major View
None Thalassemia Intermedia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Beta-Thalassemia View
None Hemoglobinopathies View
None CRISPR-Cas 12a View
None Autologous CD34+ View